Correlation Between Diageo PLC and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Diageo PLC and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diageo PLC and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diageo PLC ADR and Tscan Therapeutics, you can compare the effects of market volatilities on Diageo PLC and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diageo PLC with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diageo PLC and Tscan Therapeutics.
Diversification Opportunities for Diageo PLC and Tscan Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Diageo and Tscan is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Diageo PLC ADR and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Diageo PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diageo PLC ADR are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Diageo PLC i.e., Diageo PLC and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Diageo PLC and Tscan Therapeutics
Considering the 90-day investment horizon Diageo PLC ADR is expected to under-perform the Tscan Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Diageo PLC ADR is 3.83 times less risky than Tscan Therapeutics. The stock trades about -0.35 of its potential returns per unit of risk. The Tscan Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 489.00 in Tscan Therapeutics on August 28, 2024 and sell it today you would lose (37.00) from holding Tscan Therapeutics or give up 7.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Diageo PLC ADR vs. Tscan Therapeutics
Performance |
| Timeline |
| Diageo PLC ADR |
| Tscan Therapeutics |
Diageo PLC and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diageo PLC and Tscan Therapeutics
The main advantage of trading using opposite Diageo PLC and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diageo PLC position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Diageo PLC vs. Brown Forman | Diageo PLC vs. MGP Ingredients | Diageo PLC vs. Duckhorn Portfolio | Diageo PLC vs. Brown Forman |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |